Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Pediatr Nephrol. 2018 Aug 29;34(1):117–128. doi: 10.1007/s00467-018-4049-5

Table 1.

Lupus nephritis: baseline patient demographics [N = 89]

Variable n (% of 89) Mean ± SD
Demographics
 Age in years 15.6±3.2
 Gender Female: male 71: 18 (81%: 19%)
 Race African American 37 (42%)
Caucasian 39 (43%)
Asian 7 (8%)
Others 6 (7%)
 Ethnicity Hispanic/Non-Hispanic 10: 79 (11%: 89%)
 Blood pressure Systolic (mmHg) 124.4 ± 15.2
Diastolic (mmHg) 73.0±11.2
Clinical and laboratory descriptors
 Disease activity Renal SLEDAIΔ 7.8 ±5.2
Extra-renal SLEDAI 6.6 ±6.4
 Renal damage Renal SDI* 0.04 (0.19)
 Standard laboratory tests Protein: creatinine ratio 2.9±3.3
Serum creatinine (mg/dL) 0.85 ±0.6
GFR (mL/min/1.73m2) 133.7 ±58.9
Active urinary sediment 58 (65%)
 Angiotensin-blocking drugs 32 (36%)
Kidney biopsy interpretation
 ISN/RPS class** Class II 8 (9%)
Class III 16(18%)
Class IV 35 (40%)
Class V 29 (33%)
NIH-AI score& 8.0±6.6
NIH-CI score$ 1.7±1.3

Standard deviation

Δ

SLE disease activity index

*

Systemic Lupus Collaborating Clinics/American College of Rheumatology Damage Index

Glomerular filtration rate as per the modified Schwartz formula (Schwartz GJ et al.; J Am Soc Nephrol. 2009; 629-637)

Active urinary sediment refers to the presence of cellular casts, white cells > 5 per high power field, and/or red cells > 5 per high power field in the urine specimen

**

International Society of Nephrology/Renal Pathology Society. Overlap with class 5 is summarized under class 3 and 4 as appropriate

&

National Institutes of Health Activity Index score; range, 0-24; 0 = inactive lupus nephritis

$

National Institutes of Health Chronicity Index score; range, 0-12; 0 =no lupus nephritis damage